Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab.
Al-Shouli
Sadek
S
Abouchala
Nabil
N
Bogusz
Maciej J
MJ
Al Tufail
Mohammad
M
Thestrup-Pedersen
Kristian
K
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003374:Coumarins / Q000009:adverse effects; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004365:Drugs, Chinese Herbal / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D011687:Purines; D000068677:Sildenafil Citrate; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013450:Sulfones
D000911:Antibodies, Monoclonal; D003374:Coumarins; D003879:Dermatologic Agents; D004365:Drugs, Chinese Herbal; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000069285:Infliximab; D000068677:Sildenafil Citrate; C046627:osthol